13G Filing: Park West Asset Management and Eagle Pharmaceuticals Inc. (EGRX)

Page 8 of 8

Page 8 of 8 – SEC Filing

Exhibit A

 

 

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named
below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to
the shares of common stock, $0.001 par value per share, of Eagle Pharmaceuticals, Inc., a Delaware corporation, and further agree
that this Joint Filing Agreement be included as Exhibit A to such Schedule 13G. In evidence thereof, the undersigned hereby execute
this agreement this 24th day of August, 2017.

/s/ Peter S. Park
Peter S. Park
PARK WEST ASSET MANAGEMENT LLC
By: /s/
Grace Jimenez
Name: Grace Jimenez
Title: Chief Financial Officer

 

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

Page 8 of 8